![Class Action: Drug Makers Conspired to Overcharge for Diabetes Medication Glumetza [UPDATE]](/media/newswire-thumb-generic-drug-price-fixing.jpg)
September 20, 2019 [UPDATE] A proposed class action lawsuit out of California claims the prices of type 2 diabetes medication Glumetza and its generic version have skyrocketed due to an anticompetitive conspiracy executed by the drugs’ manufacturers.
August 10, 2018 Two ex-employees claim Lupin Pharmaceuticals poaches older individuals away from good jobs only to fire them once in possession of their business contacts.
September 6, 2017 Thirteen new cases have been filed in Pennsylvania federal court as part of a multidistrict litigation accusing numerous pharmaceutical companies of conspiring to fix the prices of generic drugs.
June 6, 2017 Seven more lawsuits have been filed this week as part of a multidistrict litigation that accuses the pharmaceutical companies of conspiring to fix generic drug prices.
